MNI researchers locate neurological basis of depression following sports concussion

Researchers at the Montreal Neurological Institute of McGill University have identified the neurological basis of depression in male athletes with persisting post-concussion symptoms. The study, published in this week’s issue of Archives of General Psychiatry, has important clinical implications for the treatment of individuals who have suffered a cerebral concussion.

Depression is one of a number of persisting symptoms experienced by athletes following sports concussion. The prevalence of depression in the general population is around 5%, whilst the prevalence of depression in head trauma patients can reach an astounding 40 %.

“Until now, very little was known about the neurological basis of the depression frequently reported by athletes following concussion,’ says Dr. Alain Ptito, neuropsychologist and researcher at the MNI, and lead investigator for the study. Traditional testing methods for concussion yielded normal results with no obvious cognitive or neurological deficits. Persistent complaints have been perceived as subjective and ill-defined without neurological basis. Injury to the brain following concussion takes place at a microscopic level and is therefore difficult to measure in a patient.

Using enhanced brain imaging technology, researchers are now able to gain new insights into the damage caused by concussion. “Using functional MRI (fMRI), a computerized imaging technique that measures blood oxygen levels, we were able to detect areas of the brain with abnormal neural activity,” explained Dr. Ptito. Dr. Ptito and colleagues tested fifty-six male athletes, 40 with concussion and 16 healthy controls. Using a depression index, 16 of the concussed subjects had no symptoms of depression, 16 expressed mild depression and 8 had moderate symptoms of depressions. Concussed athletes with depression showed reduced brain activity in regions known to be implicated in depression, specifically, the dorsolateral prefrontal cortex and striatum and attenuated deactivation in medial frontal and temporal regions. We discovered that concussed subjects with depression presented with the same pattern of brain activation as that seen for patients with major depression.”

Other studies have shown a link between a history of brain injury and probability of developing major depression later in life. Therefore understanding the pathology of depression in concussed subjects has important implications for early intervention and successful outcomes.

Source: Montreal Neurological Institute and Hospital

Related stories:

Neuroscientists Identify Brain Regions Responsible for Warding off Negative Emotion
(PhysOrg.com) -- A team of cognitive neuroscientists from Columbia University has identified the brain pathways responsible for the body's emotional defense against gruesome and other aversive forms of imagery. The study, published today in the journal Neuron, could lead to better understanding of psychological diseases, improve behavioral therapies and spawn new federal policies for hospitals and treatment centers.
Deep brain stimulation offers hope to people with treatment-resistant illnesses
Every day during a four-year deep depression, Sean Miller thought of ending his life. Nothing relieved the emotional darkness - not therapy, not medication, not loving attention from family and friends.
UC team studies link between Parkinson's disease and depression
A patient who receives a diagnosis of Parkinson's disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinson's?
Brain study could lead to new understanding of depression
(PhysOrg.com) -- Brain scientists have moved a step closer to understanding why some people may be more prone to depression than others.
Patients recover from West Nile virus after one year
(PhysOrg.com) -- People infected with West Nile virus seem to return to normal within one year of experiencing symptoms, a new McMaster study has found. The study, published today in the Annals of Internal Medicine, is the largest ever done on the long-term prognosis of West Nile virus.
FDA approves first drug for Huntington's disease
The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
Memory, depression, insomnia -- and worms?
Researchers have spent decades probing the causes of depression, schizophrenia and insomnia in humans. But a new study may have uncovered key insights into the origins of these and other conditions by examining a most unlikely research subject: worms.
Promising results in deep brain stimulation for patients with treatment-resistant depression
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.

News discussion:

Medicine & Health news